Also listed on Kotobuki Pharmaceutical Co., Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Nov 29, 2041 · Low confidence
20-year base term ends Nov 29, 2041
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Nov 29, 2021
Nov 29, 2041
Sep 3, 2024
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 29, 2021, when application PCT/JP2021/043540, the earliest non-provisional in its chain, was filed (this one was filed Nov 28, 2023); a parent in its chain could not be resolved (the next row) | Nov 29, 2041 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Nov 29, 2041 | Low confidence |
Partial family
| Application PCT/JP2021/043540 | PCT application no patent term | no patent term |
| US 12,655,122 | In force Nov 2041 | Nov 2041 |
| US 12,077,519 | this patent no later than Nov 2041 | no later than Nov 2041 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 29, 2023 Reel 65694, frame 326 | Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo | Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Nov 29, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Nov 29, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Dec 7, 2023 Reel 65809, frame 771 | Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo | Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the Address of Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 065694 Frame 0326. Assignor(S) Hereby Confirms the the Assignment. |
| Dec 7, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Astellas Pharma Inc. | Corrective Assignment to Correct the Address of Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 065694 Frame 0326. Assignor(S) Hereby Confirms the the Assignment. |
| Dec 7, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Kotobuki Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the Address of Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 065694 Frame 0326. Assignor(S) Hereby Confirms the the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 29, 2041. We will not guess the cap.